- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Alivus Life Sciences Limited — Updates, 30-07-2026: Press Release
30-07-2026 | 07:01 pm
30-07-2026 | 07:01 pm
Alivus Life Sciences delivered highest-ever PAT of Rs 160.1 Cr (up 31.8% YoY) on Rs 640.4 Cr revenue (up 6.4% YoY) for Q1FY27, driven by non-GPL business. EBITDA grew 29.1% to Rs 234.1 Cr. The company is investing in capacity expansion and R&D.
No comments yet. Be the first to comment!